Dariohealth announces two new contracts within the employer market

New york, jan. 6, 2022 /prnewswire/ -- dariohealth corp. (nasdaq: drio), a leader in the global digital therapeutics (dtx) market, announced two new contracts today to provide its highly personalized digital therapeutics beginning in the first quarter of 2022. the new clients include a large northeast regional employer in the finance industry set to deploy dario's full suite of solutions, and a northeast regional employer in the food industry contracted to deploy dario's digital therapeutic solution for diabetes.
DRIO Ratings Summary
DRIO Quant Ranking